Prime Medicine, Inc.

Historical 13F Holders

Symbol
PRME
CUSIP
74168J101
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 197 97.9 M $340 M
2025 Q4 194 97.0 M $336 M
2025 Q3 184 92.5 M $512 M
2025 Q2 129 58.7 M $145 M
2025 Q1 132 60.4 M $120 M
2024 Q4 137 64.3 M $188 M
2024 Q3 123 68.7 M $266 M
2024 Q2 129 69.1 M $355 M
2024 Q1 123 67.1 M $470 M
2023 Q4 113 49.0 M $434 M
2023 Q3 86 49.5 M $472 M
2023 Q2 80 46.1 M $676 M
2023 Q1 79 41.7 M $512 M
2022 Q4 69 41.4 M $770 M